Source comparison
Best PT-141 for HSDD: Research Formulation Comparison
The following table compares PT-141 formulations across purity verification, salt form, reconstitution compatibility, and quality documentation. All comparisons reference research-grade peptides intended for laboratory use. Real Peptides PT-141 HPLC ≥98%, MS c
This comparison does not assign a generated winner or score.
- The following table compares PT-141 formulations across purity verification, salt form, reconstitution compatibility, and quality documentation. All comparisons reference research-grade peptides intended for laboratory use.
- Real Peptides PT-141
- HPLC ≥98%, MS confirmed, AAA sequencing, <1.0 EU/mg endotoxin
- Acetate salt, reconstituted pH 5.5–6.5
- Lyophilized at −20°C stable 24+ months; reconstituted 2–8°C stable 28 days
- Full CoA with chromatogram, MS data, endotoxin test per batch
- Gold standard for HSDD research. Exact sequencing, physiological pH, transparent third-party testing
- Generic compounded PT-141
- Purity claimed but CoA often incomplete or batch-averaged
- TFA salt common, reconstituted pH 3.5–5.0
- Lyophilized stability variable; reconstituted stability unspecified
- CoA may show purity % only, no chromatogram or endotoxin data
- Acceptable for preliminary dose-ranging studies; not recommended for receptor affinity or behavioral endpoints
- Non-verified peptide vendors
- No third-party verification; purity listed as marketing claim
- Salt form unspecified
- Storage recommendations generic or absent
- No CoA provided, or CoA is templated without batch-specific data
- High risk of sequence truncation, low purity, or misidentified product. Avoid for any serious research application
- Real Peptides' PT-141 Bremelanotide formulation uses acetate salt preparation with verified amino acid sequencing and endotoxin testing below 1.0 EU/mg. The exact specifications required for CNS receptor studies where impurities or pH extremes could confound behavioral or molecular endpoints. For researchers conducting HSDD mechanism studies, melanocortin receptor binding assays, or any protocol where reproducibility depends on consistent peptide quality, the difference between verified ≥98% purity and claimed 95% purity is not 3%. It's the difference between results that replicate and results that don't.